Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

GOVX vs SIGA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

SIGA Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 7–3 Matrix Metrics)

SIGA Overall Winner 6-Pillar Tally: GOVX 0 – 6 SIGA Matrix Metrics: GOVX 3 – 7 SIGA

As of Nov 19, 2026, SIGA Technologies Inc. (SIGA) is the stronger overall head-to-head candidate over GeoVax Labs, Inc. New (GOVX) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). GOVX carries a Unified Composite Score of 26.5/100 (SELL) at $1.91 (9.7x Forward P/E, 0.0% operating margin), whereas SIGA carries 47.5/100 (HOLD) at $2.65 (2.5x Forward P/E, -14.2% operating margin).

  • Technical & Structure Timing Caution: GOVX trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 75.1); meanwhile SIGA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About GOVX vs SIGA
GOVX NASDAQ
GeoVax Labs, Inc. New
Pharmaceutical Preparations
$1.91
-4.02% 1D
Market Cap $1.1M
TTM Revenue N/A
Forward P/E 9.7x
Beta / 30D Vol 16.91β · 6225% Vol
Unified Composite Score
26.5 / 100 SELL
Tech 50.0 Fund 30.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (17.9% over 20 days), RSI 75
RSI-14: 75.1 · SMA20: $0.80 · SMA50: $0.51
SIGA NASDAQ Head-to-Head Winner
SIGA Technologies Inc.
Pharmaceutical Preparations
$2.65
-5.36% 1D
Market Cap $187.9M
TTM Revenue $52M
Forward P/E 2.5x
Beta / 30D Vol 0.75β · 65% Vol
Unified Composite Score
47.5 / 100 HOLD
Tech 40.0 Fund 56.0 Flow 69.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -0.6%), weak momentum, RSI 37
RSI-14: 36.7 · SMA20: $3.02 · SMA50: $3.14

6-Pillar Scorecard Institutional Category Breakdown (GOVX 0 – 6 SIGA)

Columns: Metric · GOVX · SIGA
1. Valuation Multiples SIGA
Forward P/E 9.7x 2.5x
Trailing P/E 9.7x N/M
PEG Ratio N/M 3.37x
EV / Revenue N/M 1.4x
2. Growth & Scale SIGA
Revenue Growth (YoY) -100.0% -49.7%
Earnings Growth (YoY) +0.0% -65.3%
TTM Revenue (USD) N/A $52M
Market Cap $1.1M $187.9M
3. Profitability & Quality SIGA
Gross Margin N/A 23.4%
Operating Margin 0.0% -14.2%
Net Profit Margin 0.0% 1.3%
Return on Equity (ROE) -891.6% 0.4%
4. Balance Sheet & Cash Flow SIGA
Cash Generation (TTM) N/A -$12M
Cash Flow Margin N/A -22.1%
Net Cash / Leverage $2.8M Net Cash $116M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning SIGA
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile N/A (N/A) 81.4% (8th %ile)
Put/Call OI Skew N/A 0.04x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markup DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat SIGA
OpEx & R&D Intensity N/A 37.6% of Rev ($20M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Drug Manufacturers - Specialty & Generic Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: GOVX (3) vs SIGA (7)
Institutional Metric GOVX SIGA Criterion Row Edge
Market Capitalization
Scale
$1.1M $187.9M Larger Scale SIGA
Trailing P/E Ratio
Valuation
9.7x N/M Lower Multiple GOVX
Forward P/E Ratio
Valuation
9.7x 2.5x Lower Multiple SIGA
Revenue Growth (YoY)
Growth
-100.0% -49.7% Higher Growth SIGA
Operating Margin (TTM)
Profitability
0.0% -14.2% Higher Margin GOVX
Net Profit Margin
Profitability
0.0% 1.3% Higher Margin SIGA
Return on Equity (ROE)
Capital Efficiency
-891.6% 0.4% Higher ROE SIGA
52-Week Range Position
Momentum
42% ($0–$4) 3% ($3–$7) Stronger Trend GOVX
Beta / 30D Volatility
Risk Regime
16.91β · 6225% Vol 0.75β · 65% Vol Lower Realized Risk SIGA
Unified Institutional Score
Composite Signal
26.5 / 100 (SELL) 47.5 / 100 (HOLD) Higher Composite SIGA
Trailing 12M Revenue (USD)
Operating Scale
N/A $52M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 23.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev 3.37x PEG · 1.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($2.8M Net Cash) -$12M ($116M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon GOVX +737.63 pp
GOVX: +722.57% · SIGA: -15.06%
3M Horizon GOVX +208.68 pp
GOVX: +195.85% · SIGA: -12.83%
6M Horizon GOVX +13.19 pp
GOVX: -30.55% · SIGA: -43.74%
1Y Horizon GOVX +423.75 pp
GOVX: +368.14% · SIGA: -55.61%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period GOVX Revenue SIGA Revenue GOVX Op. Margin SIGA Op. Margin Margin Leader
FY2018 $0M $480M -266.1% 74.4% SIGA
FY2019 $0M $30M -201.8% -8.7% SIGA
FY2020 $0M $120M -154.5% 67.6% SIGA
FY2021 $0M $130M -4862.7% 66.7% SIGA
FY2022 $0M $110M -17207.5% 38.5% SIGA
FY2023 N/A $140M N/A 59.8% SIGA
FY2024 $0M $140M -635.8% 50.4% SIGA
FY2025 $0M $90M -869.3% 25.1% SIGA

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
GOVX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GOVX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SIGA CONSOLIDATION
33d in phase · OBV DISTRIBUTION
Current IV 81.4%
IV Percentile 8th %ile
Put/Call OI Skew 0.04x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact SIGA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
GOVX Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $1.1M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
SIGA Moat Profile Cyclical / Execution-Driven Positioning
Drug Manufacturers - Specialty & Generic Operator
Competes within the Drug Manufacturers - Specialty & Generic value chain with $187.9M market capitalization and -14.2% operating margin.
OpEx & R&D Reinvestment 37.6% of Rev ($20M)
90D Engineering Disclosures 0 Published

Investor FAQ GOVX vs SIGA Key Questions & Quantitative Answers

As of Nov 19, 2026, SIGA Technologies Inc. (SIGA) is the stronger overall head-to-head candidate over GeoVax Labs, Inc. New (GOVX) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). GOVX carries a Unified Composite Score of 26.5/100 (SELL) at $1.91 (9.7x Forward P/E, 0.0% operating margin), whereas SIGA carries 47.5/100 (HOLD) at $2.65 (2.5x Forward P/E, -14.2% operating margin). Technical & Structure Timing Caution: GOVX trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 75.1); meanwhile SIGA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

SIGA leads the Growth & Scale pillar: GOVX posts -100.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with SIGA at -49.7% YoY revenue growth and -65.3% YoY earnings growth on $52M TTM revenue (23.4% gross margin, -14.2% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), GOVX cumulative revenue shifted N/A while SIGA shifted -81.2%. In operating R&D and SG&A reinvestment, GOVX deploys N/A (0 90-day corporate R&D disclosures) versus 37.6% of Rev ($20M) (0 disclosures) for SIGA.

SIGA screens cheaper on headline valuation multiples. GOVX trades at 9.7x Forward P/E, 9.7x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas SIGA trades at 2.5x Forward P/E, N/M Trailing P/E, 3.37x PEG, and 1.4x EV/Revenue (-22.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GOVX (-891.6% ROE) versus SIGA (0.4% ROE) capital efficiency.

In options market volatility and institutional positioning, GOVX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (16.91β · 6225% Vol realized risk). By comparison, SIGA carries 81.4% implied volatility (8th %ile, Compressed (<25th %ile)), a 0.04x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.75β · 65% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.